1. Home
  2. PRTH vs LRMR Comparison

PRTH vs LRMR Comparison

Compare PRTH & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Priority Technology Holdings Inc.

PRTH

Priority Technology Holdings Inc.

HOLD

Current Price

$5.45

Market Cap

440.2M

Sector

Technology

ML Signal

HOLD

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

HOLD

Current Price

$4.02

Market Cap

455.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRTH
LRMR
Founded
2005
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
440.2M
455.8M
IPO Year
2016
2014

Fundamental Metrics

Financial Performance
Metric
PRTH
LRMR
Price
$5.45
$4.02
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$8.33
$16.50
AVG Volume (30 Days)
426.6K
908.7K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
319.35
N/A
EPS
0.23
N/A
Revenue
N/A
N/A
Revenue This Year
$9.76
N/A
Revenue Next Year
$6.79
$1,816.14
P/E Ratio
$24.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.44
$2.72
52 Week High
$7.90
$6.42

Technical Indicators

Market Signals
Indicator
PRTH
LRMR
Relative Strength Index (RSI) 43.04 46.59
Support Level $5.16 $3.57
Resistance Level $5.47 $4.21
Average True Range (ATR) 0.24 0.17
MACD 0.04 -0.05
Stochastic Oscillator 38.46 29.03

Price Performance

Historical Comparison
PRTH
LRMR

About PRTH Priority Technology Holdings Inc.

Priority Technology Holdings Inc is a fintech company that provides payment and banking-related solutions, including services for collecting, storing, lending, and transferring money for businesses. The company has three reportable segments: i) Merchant Solutions: Provides full-service acquiring and payment-enabled solutions for B2C transactions, ii) Payables: Provides AP automation solutions to corporations, software partners and FIs in addition to improving cash flows by providing instant access to working capital and iii) Treasury Solutions: Provides embedded finance and BaaS solutions to customers to modernize legacy platforms and accelerate software partners' strategies to monetize payments. The majority of the company's revenue is derived from the Merchant Solutions segment.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: